Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new blog authored by mental health clinicians and researchers in the Department of Psychiatry and Oxford Health NHS Foundation Trust, and published in thebmjopinion, discusses the priority groups for COVID-19 vaccinations.

Coronavirus vaccine concept in blue jar in hand of doctor

The news of the first Medicines and Healthcare products Regulatory Agency (MHRA) approved vaccine for COVID-19 on 2 December 2020, with plans for large-scale implementation of a vaccination programme in the UK and other countries, has brought great hope and expectation.

Vaccination will be a crucial step in reducing infection rates and offering a realistic way out of pandemic restrictions. However, there are limited supplies of vaccine, the logistics are challenging, and each country needs to prioritise who receives it first and in what order. 

Dr Katharine Smith, Honorary Consultant Psychiatrist, Department of Psychiatry, University of Oxford, said:

 

‘Guidance on priority groups for COVID-19 vaccination in the UK includes severe mental illness (in priority group 6), but the focus here and in other countries is on the single highest priority criterion met. In the real world, many people have multiple risks factors across mental and physical health, and we already know that they have a low uptake of preventative health strategies. Without more specific prioritisation and strategies to support uptake, our blog highlights the very real risk that this most vulnerable group will simply get left behind.’ 

Read the full blog at thebmjopinion.

For more information on vaccine prioritisation and mental health.

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

What is the Role of Science in Mental Health?

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

New Research Presented at the ECNP Conference - October 2021

Dr Angharad de Cates and Dr Liliana Capitão were just two of the department's researchers presenting and publishing new research at the European College of Neuropsychopharmacology (ECNP) Conference 2021, in Lisbon.

Researchers Address Mental Health Effects of the Pandemic on Young People

In a new policy briefing, a team of researchers at King’s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK through their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.

Turing Fellowships for Over 30 Oxford Academics

Professor John Geddes, WA Handley-elect Chair of Psychiatry, is one of the thirty-three University of Oxford researchers, which have been named Turing Fellows for the 2021/22 academic year.

Simple Intervention Effectively Treats Depression During COVID 19

New research shows that even a very simple intervention, administered by non-specialists with just 15 hours of training, can effectively treat depression during COVID-19.

Over a Third of COVID-19 Patients Diagnosed with at Least One Long-COVID Symptom

A new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.